We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AVGO:NASDAQBroadcom Inc. Analysis

Data as of 2026-05-29 - not real-time

$426.58

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Broadcom (AVGO) is trading at $426.58, comfortably above its 20‑day SMA of $421.44 and the 50‑day SMA of $383.08, indicating a short‑term bullish bias. The 200‑day SMA sits at $351.63, reinforcing a longer‑term uptrend. Momentum remains neutral‑to‑positive with an RSI of 58 and a bullish trend direction, though the MACD histogram has turned negative, hinting at possible near‑term weakness. Technical support is anchored at $404.23 and resistance near $442.36, placing the stock within a relatively tight range. Volatility is elevated at 37% over the past 30 days and beta exceeds 2, suggesting the share price will swing sharply on market moves. Fundamental metrics show a trailing P/E of 83 versus an industry average of 41, and a DCF‑derived fair value of $183, flagging significant overvaluation despite robust operating margins and a 29.5% revenue growth rate.
Nevertheless, the company delivers 76.7% gross margin, 44.9% operating margin and generates $25.5 B of free cash flow, supporting a 0.61% dividend yield with a 47% payout ratio, which appears sustainable. Analysts are overwhelmingly positive, assigning a “strong buy” consensus and a median price target of $495, implying roughly 13% upside from current levels. Recent material news includes a renewed five‑year partnership with the London Stock Exchange Group and heightened positioning in next‑gen data‑center and AI chip markets. The forward P/E compresses to 23, reflecting expected earnings acceleration, while the forward EPS of $18.40 signals strong growth potential. Given the blend of strong cash generation, attractive dividend and secular AI demand, the stock is a compelling candidate for medium‑term accumulation despite current pricing pressure. Investors should monitor the MACD turn‑negative signal and the $442 resistance as triggers for short‑term positioning.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical resistance at $442
  • Negative MACD histogram indicating short‑term weakness
  • High volatility and beta increasing downside risk

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth and high operating margins
  • Forward P/E compression to 23 with accelerating EPS
  • Strategic AI and data‑center positioning plus renewed LSEG partnership

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Sustainable dividend with solid cash flow generation
  • Long‑term secular demand for semiconductor and infrastructure software
  • Current valuation premium may require price correction before full upside

Key Metrics & Analysis

Financial Health

Revenue Growth29.50%
Profit Margin36.57%
P/E Ratio83.3
ROE33.37%
ROA10.66%
Debt/Equity82.70
P/B Ratio25.3
Op. Cash Flow$29.7B
Free Cash Flow$25.5B
Industry P/E40.9

Technical Analysis

TrendBullish
RSI58.4
Support$404.23
Resistance$442.36
MA 20$421.44
MA 50$383.08
MA 200$351.63
MACDBearish
VolumeStable
Fear & Greed Index93.2

Valuation

Fair Value$183.32
Target Price$481.97
Upside/Downside12.98%
GradeOvervalued
TypeGrowth
Dividend Yield0.61%

Risk Assessment

Beta2.06
Volatility37.12%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.